CervoMed (CRVO) Stock: Buy, Sell, or Hold?
CRVO - CervoMed Inc. Common Stock
$2.41
-0.02 (-0.82%)
▼
5d:
-4.74%
30d:
-5.86%
90d:
-41.65%
WAIT
LOW Confidence
Analysis Updated: Sep 21, 2026 12:00 AM ET
Earnings: Nov 06, 2026
Get Alerted When CRVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CRVO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CRVO shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CRVO is currently trading at $2.41, which is considered oversold relative to its 30-day fair value range of $2.49 to $2.65.
Technical Outlook: Technically, CRVO is in a downtrend. The price is currently testing key support at $2.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $15.40 (+539.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRVO is in a downtrend. The price is currently testing key support at $2.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $15.40 (+539.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.49 -
$2.65
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 539.0% below Wall St target ($15.40)
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.49 -
$2.65
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.40
Resistance Level
$2.64
Current Trend
Downtrend
Technical data as of
Sep 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.63
Wall Street Target
$15.40
(+539.0%)
Revenue Growth (YoY)
-99.6%
Share & Embed Analysis
Last updated: September 22, 2026 9:08 AM ET
Data refreshes hourly during market hours. Next update: 10:08 AM
Data refreshes hourly during market hours. Next update: 10:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1181 | 55 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$48 | 50 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$138 | 63 BUY |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 31 SELL |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$118 | 61 BUY |
